VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,494 | -34.4% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $28,212 | -2.9% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $29,068 | -11.4% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $32,792 | -21.9% | 4,281 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $42,000 | -8.7% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $46,000 | -4.2% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $48,000 | -28.4% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -8.2% | 4,281 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $73,000 | -20.7% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $92,000 | +43.8% | 4,281 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $64,000 | +14.3% | 4,281 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $56,000 | +36.6% | 4,281 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $41,000 | -16.3% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $49,000 | +11.4% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $44,000 | -37.1% | 4,281 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $70,000 | +22.8% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $57,000 | -5.0% | 4,281 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $60,000 | -24.1% | 4,281 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $79,000 | -29.5% | 4,281 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $112,000 | +14.3% | 4,281 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $98,000 | +32.4% | 4,281 | +10.7% | 0.01% | +25.0% |
| Q2 2018 | $74,000 | +13.8% | 3,866 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $65,000 | +10.2% | 3,866 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $59,000 | -10.6% | 3,866 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $66,000 | +4.8% | 3,866 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $63,000 | +57.5% | 3,866 | +35.4% | 0.00% | +50.0% |
| Q1 2017 | $40,000 | – | 2,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |